Page last updated: 2024-08-24
halofuginone and Intervertebral Disc Degeneration
halofuginone has been researched along with Intervertebral Disc Degeneration in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chen, C; Gao, Y; Li, S; Luo, L; Shao, Z; Wu, X; Xiong, L; Yang, C | 1 |
Other Studies
1 other study(ies) available for halofuginone and Intervertebral Disc Degeneration
| Article | Year |
|---|---|
Halofuginone attenuates intervertebral discs degeneration by suppressing collagen I production and inactivating TGFβ and NF-кB pathway.
Topics: Animals; Collagen Type I; Female; Intervertebral Disc Degeneration; NF-kappa B; Piperidines; Quinazolinones; Rabbits; Signal Transduction; Transforming Growth Factor beta | 2018 |